• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    9.00 Down 0.73(7.50%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:9.73
    Open:9.83
    Bid:9.03 x 200
    Ask:N/A
    1y Target Est:13.67
    Beta:0.94
    Next Earnings Date:N/A
    Day's Range:8.97 - 9.90
    52wk Range:2.46 - 13.74
    Volume:759,120
    Avg Vol (3m):1,370,640
    Market Cap:212.80M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 7.50%212.80M
    BVTI 0.00%N/A
    DNDN 0.00%N/A
    VICLUp 0.99%92.44M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):230.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.11
    Quarterly EPS Est (Jan-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback